Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/38971| Title: | Accelerated vs regular approval, differences in study characteristics of lung cancer treatments approved by the US Food and Drug Administration |
| Authors: | RIBEIRO, Tatiane; BUSS, Lewis; ALI, Sanni; NOBRE, Moacyr |
| Citation: | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, v.29, suppl.3, Special Issue, p.163-163, 2020 |
| Appears in Collections: | Comunicações em Eventos - HC/InCor Comunicações em Eventos - LIM/23 Comunicações em Eventos - LIM/38 |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.